Category: <span>Banned drug information</span>

Category: Banned drug information

First-line treatment for bipolar disorder Priadel to be discontinued in UK from April 2021

The planned discontinuation of first-line bipolar disorder treatment Priadel has caused concern that some patients could relapse and face hospitalisation. The manufacturer of first-line bipolar disorder treatment Priadel is discontinuing production of the medicine, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced — causing concerns that patients could relapse and face hospital admission. A supply disruption alert (SDA) issued by …

Banned drug information | Drug safety alert | News

Lupin, Marksans Pharma, Aurobindo Pharma and Alembic Pharmaceuticals are recalling products in the US markets

Indian drug firms like Lupin, Marksans Pharma, Aurobindo Pharma and Alembic Pharmaceuticals are recalling products in the US market, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in …

Banned drug information | Drug safety alert | Medication Alerts | News

MAGEC rods suspension in UK market

Manufactured by NuVasive Specialized Orthopedics – supply of all MAGEC rods suspended to the UK market during a review by MHRA. The MAGEC® System is used to brace the spine during growth to minimize the progression of scoliosis. The MAGEC System is a metallic implant. The end cap is a threaded …

Banned drug information

FDA request withdrawal of bacitracin injection

The U.S. Food and Drug Administration has requested that all current manufacturers of bacitracin for injection voluntarily withdraw their product from the market. Bacitracin for injection is currently FDA-approved to treat infants with pneumonia and empyema (a collection of pus in the space between the membranes lining the lungs) caused …

Banned drug information | Drug safety alert

Safety alert: EMA suspends Picato as a precaution while review of skin cancer risk continues

EMA’s safety committee (PRAC) recommended that patients stop using Picato (ingenol mebutate) manufactured by LEO Pharma, a gel for treating the skin condition actinic keratosis, while it continues its review of the medicine’s safety. The PRAC is currently reviewing data on skin cancer in patients using Picato. While uncertainties remain, …

Banned drug information | Drug safety alert

U DREAM PRODUCT Recall by HEALTH CANADA

Health Canada has tested several U-Dream Lite and U-Dream Full Night herbal sleep-aid products and has found that they contain a substance similar to the prescription drug zopiclone, which may pose serious health risks. Health Canada tested the products after receiving complaints of unusual side effects—such as symptoms of withdrawal …

Banned drug information

Recall of two lots of Relpax – migraine headache medicine

On 15 Aug 2019, Pfizer issued the voluntarily recalling of migraine headache medicine RELPAX® (eletriptan hydrobromide) 40 mg tablets, lots AR5407 and CD4565, to the Patient level. Pfizer initiated this recall because these product lots may not meet Pfizer’s in-house microbiological specification for the potential presence of Genus Pseudomonas and Burkholderia. …

Banned drug information

Giving Cough and Cold medications to Kids

The FDA issued public health advisory about children’s cold medicines. FDA stated children under 2 years of age should not be given any kind of cough and cold product that contains a decongestant or antihistamine because serious and possibly life-threatening side effects could occur. Reported side effects of these products included …

Banned drug information
error: Content is protected !!